Document:

Exhibit 10.1

 

Conformed Copy

 

AXCELIS TECHNOLOGIES, INC.

 

EXECUTIVE SEPARATION AGREEMENT

 

THIS EXECUTIVE SEPARATION AGREEMENT, dated as of February 10, 2012, is made by and between Axcelis Technologies, Inc. (hereinafter referred to as the “Company”) and Matthew P. Flynn (hereinafter referred to as “Executive”).  In consideration of the mutual covenants contained herein, the parties agree as follows:

 

1.                                       Separation Date.   Executive’s employment with the Company will terminate on February 24, 2012 (the “Termination Date”).  As described in Section 2, Executive will receive the separation pay and benefits under this Agreement.  Prior to the Termination Date, the Executive shall cooperate with the reasonable requests of the Company to support the transition of the Executive’s duties to other Company personnel.  Since your separation is occurring in connection with a reduction in force, we are also providing you with information on the other affected employees as set forth in Schedule 1 hereto (Information as to Layoff).

 

2.                                       Separation Compensation.

 

2.1.                  Accrued Obligations.  Employee has been or will be as of the Termination Date paid in full for any and all wages, including accrued but unused vacation time.

 

2.2.                  Separation Pay.  The Company will make 39 weeks of Executive’s full base pay at the weekly rate of $6,730.76, less legally required payroll taxes, payable bi-weekly in accordance with the Company’s usual payroll cycle.

 

2.3.                  Axcelis Time Management (ATM).  After the Termination Date, Executive will receive a lump sum amount for his accrued ATM balance, if any. Overdrawn ATM time will be deducted from Executive’s final paycheck.

 

2.4.                  COBRA Payments.  If Executive elects to continue health coverage under the Company’s health plan in accordance with COBRA, the Company will pay for the full cost of such coverage until the earlier of (i) the date Executive begins full-time employment or full-time self-employment; or (ii) the end of the ninth month after the Termination Date (November 30, 2012).

 

2.5.                  Benefits.  Detailed information on the impact of Executive’s separation on Company-provided benefits is set forth on Attachment A which is attached hereto and incorporated herein.

 

 

2.6.                  Transition Assistance.  During the period (the “Transition Period”) from the Termination Date until August 24, 2012 (the date 6 (six) months after the Termination Date), the following provisions will apply:

 

(a)                                  Email.  The Company agrees to allow Executive to maintain webmail access to the Executive’s Axcelis email account until the earlier of the end of the Transition Period or the date on which Executive commences other employment.

 

(b)                                 Cell Phone.  The Company agrees to assign to the Executive the mobile phone owned by the Company and used by the Executive as of the Termination Date and pay the Executive a lump sum amount to cover six months’ of cell phone premiums at the Executive’s plan level (but not more than $99 per month).

 

(c)                                  Outplacement.  At the request of Executive, the Company will pay up to $12,500 for an outplacement service for services rendered in assisting Executive in locating other employment, provided such payments are contingent upon Executive’s cooperation with the outplacement service and upon active efforts by Executive to locate another position.

 

2.7.                  Equity Actions.  The following modifications to equity grants held by the Executive will be effective on the Termination Date:

 

(a)                                  Acceleration of Vesting of Stock Options.  The Compensation Committee of the Board of Directors has resolved, in accordance with Section 6.03(c) of the 2000 Stock Plan, to accelerate the vesting of certain non-qualified stock options held by the Executive as set forth on Schedule 2 hereto.

 

(b)                                 Retirement Exercisability of Stock Options.  As provided in Section 6.03(e)(i) (B) of the 2000 Stock Plan, the vested non-qualified stock options held by the Executive remain exercisable until  February 24, 2013, which is the first anniversary of the Executive’s termination of employment, as set forth on Schedule 2 hereto.

 

3.                                       Executive Acknowledgement of Compensation. The Executive acknowledges that in exchange for entering into this Agreement the Executive has received good, sufficient and valuable consideration in excess of that to which the Executive would otherwise have been entitled in the absence of this Agreement.  The Executive acknowledges that the Executive has been paid in full for any and all wages, including accrued unused vacation pay.  Unless otherwise provided for expressly in this Agreement, all other benefits have ceased as of the Termination Date.

 

4.                                       Effect of Breach on Compensation.   The Executive agrees that the compensation and benefits contained in this Agreement and which flow to the Executive from the Company are subject to termination, reduction or cancellation in the event that the Executive takes any action or engages in any conduct deemed by the Company to be in violation of this Agreement, provided however, that prior to any such termination , the Company will notify the

 

 

Executive of the particular concern and provide the Executive with a reasonable opportunity to cure.

 

5.                                       Executive Obligations.

 

5.1.                  Return of Property.  The Executive shall return all papers, files, documents, computers, reference guides, equipment, keys, identification, credit cards, software, computer access codes, disks and institutional manuals, or other property belonging to the Company within one week after the Termination Date; provided the Executive shall return the laptop computer referenced in Section 2 above not later than the end of the Transition Period. The Executive shall not retain any copies, duplicates, reproductions or excerpts of any of the Company’s property.   The Executive may retain copies of all agreements between the Executive and the Company and other documents relating to his personal performance.

 

5.2.                  Nondisclosure of Confidential Information.  During the course of the Executive’s employment with the Company, the Executive has become acquainted with and/or developed confidential information belonging to the Company and its customers. The Executive agrees not to use or to disclose to any person or entity any confidential information of the Company or of any past or present customer of the Company, including but not limited to financial data or projections, customer lists, projects, economic information, systems, plans, methods, procedures, operations, techniques, know-how, trade secrets or merchandising or marketing strategies. In addition, Executive shall continue to be bound by the terms of  Employee Invention Assignment, and Confidentiality Agreement, which the Executive executed in connection with his employment. The form of that Agreement is affixed hereto and incorporated by reference as Attachment B. The provisions of this Section 5.2 shall not apply to any such confidential information that is (a) presently publicly available or a matter of public knowledge or public domain generally without breach of this Agreement, or (b) lawfully received by the Executive from a third party who is or was not bound in any confidential relationship to the Company, or (c) required to be disclosed by the Executive pursuant to judicial or government order, provided the Executive shall give the Company reasonable notice prior to such disclosure and shall comply with any applicable protective order.

 

5.3.                  Nondisparagement.  Provided the Executive is not in breach of his obligations under this Agreement, the Company agrees not to disparage or make negative statements about the Executive. The Executive agrees not to disparage or make negative statements about the Company or any of its officers, directors, agents, employees, successors and assigns.

 

5.4.                  Non-Compete and Non-Solicitation.  The Executive hereby agrees with the Company that for a period of 12 months following the Termination Date:

 

(a)                                  The Executive shall not, without the prior written consent of the Chief Executive Officer of the Company, directly or indirectly, engage in, be employed by, act as a consultant or advisor to, be a director, officer, owner or partner of, or acquire an interest in, any business engaged in manufacturing implant or dry strip semiconductor processing systems (a

 

 

“competitive business”), nor directly or indirectly have any interest in, own, manage, operate, control, be connected with as a stockholder, lender, joint venturer, officer, employee, partner or consultant, or otherwise engage, invest or participate in any competitive business; provided, however, that nothing contained in this Section 5.4 shall prevent the Executive from investing or trading in publicly traded stocks, bonds, commodities or securities or in real estate or other forms of investment for Executive’s own account and benefit (directly or indirectly);

 

(b)                                 The Executive shall not actively solicit any employee of the Company or any of its subsidiaries or affiliates to leave the employment thereof; and the Executive shall not enter onto Company property without prior written consent from the Chief Executive Officer of the Company or other executive officer of the Company;

 

(c)                                  The Executive shall not induce or attempt to induce any customer, supplier, licensor, licensee or other individual, corporation or business organization having a business relationship with the Company or its subsidiaries or affiliates to cease doing business with the Company or its subsidiaries or affiliates or in any way interfere with the relationship between any such customer, supplier, licensor, licensee or other individual, corporation or business organization and the Company or its subsidiaries or affiliates.  Solicitation of customers for the purposes of this obligation refers to existing and/or contemplated products as of the time of this Agreement;

 

(d)                                 The applicable time periods set forth in this Section 5.4 shall be extended by the time of any breach by the Executive of any terms of this Agreement;

 

(e)                                  The provisions of Section 5.4 contain the sole and exclusive obligations of the Executive with respect to non-competition and non-solicitation other than those provided by law, if any; and

 

(f)                                    The Company acknowledges that negotiations or discussions between or among Executive and any third party about prospective employment, business ventures, or other opportunities shall not, alone, constitute a breach of Section 5.4(a) of this Agreement.

 

5.5.                  Resignations from Corporate Office.  Not later than the Termination Date, the Executive will execute and deliver to the Company his resignation as an officer or director of the Company and its subsidiaries and joint ventures, attached here to as Attachment C.  From time to time on or after the Termination Date, the Executive will execute such resignations from offices held in the Company’s subsidiaries, as the Company may reasonably request.  Executive expressly acknowledges that the compensation payable to Executive under this Agreement is in full satisfaction of any compensation due to him in connection with his corporate positions described in this Section 5.5.  It is understood that the force and effect of Attachment C arises exclusively in the context of, and as part of, this Agreement.

 

5.6.                  Cooperation.  The Executive will cooperate fully with the Company in its defense of or other participation in any administrative, judicial or other proceeding arising from any charge, complaint or other action which has been or may be filed against the Company and

 

 

with respect to which Executive has knowledge, provided, however, that the Company will pay all reasonable costs associated with such cooperation, including compensation for the Executive’s time at the Executive’s usual, and reasonable, rate.  The Executive agrees to be responsive to requests for information related to the smooth transition of a successor to his position.

 

6.                                       SEC Reporting and Applicability of the Company’s Insider Trading Policy.

 

6.1.                  Rule 144.  For the purposes of Rule 144 promulgated by the Securities Exchange Commission, the Executive shall cease to be an “affiliate” of  the Company on the Termination Date.

 

6.2.                  Section 16 Reporting.  The Executive shall cease to be a reporting person under the Securities Exchange Act of 1934, as amended, as of the Termination Date, provided however, the Executive must file a Form 4 with the SEC to report any purchase, sale, or option exercise after the Termination Date if the transaction occurs within six months following a Form 4 transaction going the opposite way (e.g., sale vs. purchase) prior to the Termination Date.

 

7.                                       Insider Trading Policy.  Assuming the Executive does not acquire material non-public information after the Termination Date, beginning on the date two trading days after the Company’s public announcement of its earnings for the first fiscal quarter ending after the Termination Date, the Executive will no longer be subject to restrictions on trading arising under the Company’s insider trading policy.

 

8.                                       General Release and Covenant Not to Sue.

 

8.1.                  Release.  In consideration of the Company’s covenants in this Agreement, the Executive hereby releases and discharges the Company and its officers, directors, agents, employees, successors and assigns (“Released Parties”) from any and all claims by the Executive arising before the signing of this Agreement, including all claims arising out of the Executive’s employment with the Company or the termination thereof  (except (1) those relating to performance of this Agreement and (2) the Company’s obligations under the Indemnification Agreement between the Executive and the Company dated June 26, 2003, the form of which is attached hereto as Attachment D (the “Indemnification Agreement”)) and claims arising under common law and claims arising under federal or state labor and employment laws and laws prohibiting discrimination on the basis of age, sex, race, national origin or disability. The laws referred to in the preceding sentence include Title VII of the Civil Rights Act of 1964, as amended; the Equal Pay Act of 1963, as amended; the Age Discrimination in Employment Act of 1967 (ADEA), as amended; the Fair Labor Standards Act of 1938, as amended; the Americans With Disabilities Act of 1990, as amended; the Rehabilitation Act of 1973, as amended; the Family and Medical Leave Act of 1993, as amended; Chapter 151B of the Massachusetts General Laws, Chapter 149 of the Massachusetts General Laws; the Massachusetts Civil Rights Act and the Massachusetts Equal Rights Law; the Worker Adjustment and Retraining Notification (“WARN”) Act; or any other state or federal law, order, public policy or regulation affecting or relating to the

 

 

rights and/or claims of employees.  Nothing in this Agreement shall be construed to be a release of certain ADEA and Title VII rights that is not allowed by law, except that the Executive waives and shall not accept any damages from any such claims.

 

8.2.                  Covenant Not to Sue.  The Executive represents and warrants that he has not filed any complaints, charges, or claims for relief against the Released Parties with any local, state or federal court or administrative agency.  The Executive agrees and covenants not to sue or bring any claims or charges against the Released Parties with respect to any matters arising out of or relating to the Executive’s employment with or separation from the Company, other than enforcement of the terms of this Agreement or the Indemnification Agreement.  In the event that the Executive institutes any such action, that claim shall be dismissed upon presentation of this Agreement and he shall reimburse the Company for all legal fees and expenses incurred in defending such claim and obtaining its dismissal.

 

8.3.                  No Implied Admission.  It is understood and agreed that this Agreement does not constitute any admission by the Company that any action taken with respect to the Executive was unlawful or wrongful, or that such action constituted a breach of contract or violated any federal or state law, policy, rule or regulation.

 

9.                                       Compliance with Federal Older Workers Benefit Protection Act of 1990.

 

9.1.                  Time to Consider Agreement.  The Executive acknowledges that he has been advised in writing to consult with an attorney and has had ample opportunity to consult with and review this Agreement with an attorney of his choice, and has been given a period of at least forty-five (45) days within which to consider whether to sign this Agreement.  If the Executive has signed this Agreement prior to the end of this forty-five (45) day period, he represents that he has done so knowingly and voluntarily.

 

9.2.                  Revocation Right.  It is agreed and understood that for a period of seven (7) days following the execution of this Agreement, which period shall end at 5:00 p.m. on the seventh day following the date of execution by the Executive, he may revoke this Agreement.  This Agreement will not become effective until this revocation period has expired.  This seven (7) day revocation period cannot be shortened by agreement of the parties or by any other means.

 

10.                                 Miscellaneous.

 

10.1.            Availability of Equitable Remedies.  The Executive agrees and warrants that the covenants contained herein are reasonable, that valid consideration has been and will be received therefor and that the agreements set forth herein are the result of arms-length negotiations between the parties hereto.  The Executive recognizes and acknowledges that the provisions of Section 5 are vitally important to the continuing welfare of the Company, and its subsidiaries and affiliates, and that money damages constitute a totally inadequate remedy for any violation thereof.  Accordingly, in the event of any such violation by the Executive, the Company, and its subsidiaries and affiliates, in addition to any other remedies they may have, shall have the right to

 

 

institute and maintain a proceeding to compel specific performance thereof or to obtain an injunction restraining any action by the Executive in violation of Section 5.

 

10.2.            Severability.   In the event that any provision of this Agreement is found by a court, arbitrator or other tribunal to be illegal, invalid or unenforceable, then such provision shall not be voided, but shall be enforced to the maximum extent permissible under applicable law, and the remainder of this Agreement shall remain in full force and effect.

 

10.3.            Entire Agreement.  This Agreement and its Exhibits constitutes the entire agreement between the parties about or relating to the Executive’s termination of employment from the Company, or the Company’s obligations to the Executive with respect to his termination and fully supersedes any and all prior agreements (including but not limited to the Change of Control Agreement between the Company and the Executive dated May 12, 2005) or understanding between the parties, other than the Indemnification Agreement.  The Company represents and warrants that there has been no Change of Control as defined in the above-mentioned Change of Control Agreement prior to the date hereof and that no Change of Control transaction is contemplated by the Company as of the date hereof.   Upon execution of this Agreement, the obligations of the Executive and the Company relating to the Executive’s employment by the Company will arise solely and exclusively out of this Agreement and the Indemnification Agreement.

 

10.4.            Binding Benefit.  This Agreement shall be binding on the parties and upon their heirs, administrators, representatives, executors, successors and assigns and shall inure to their benefit and to that of their heirs, administrators, representatives, executors, successors and assigns.

 

10.5.            Amendments.  This Agreement may not be altered, amended or modified, except by a further written document signed by the Executive and the Company.

 

10.6.            Governing Law. This Agreement shall be governed by the laws of the Commonwealth of Massachusetts, without regard to or application of choice-of-law rules or principles.

 

10.7.            Limitations on Recovery.  In the event that the Executive institutes legal proceedings to enforce this Agreement, he agrees that the sole remedy available shall be enforcement of the terms of this Agreement and/or a claim for damages resulting from the breach of this Agreement, but that under no circumstances shall the Executive be entitled to receive or collect any damages for claims that Executive has released under this Agreement.

 

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first set forth above.

 

 

	
 
    	
AXCELIS   TECHNOLOGIES, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Lynnette C. Fallon
    
	
 
    	
Title:   Lynnette C. Fallon, EVP HR/Legal and General Counsel
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
/s/   Matthew P. Flynn
    
	
 
    	
Matthew   P. Flynn
    

 

Attachments

 

	
Schedule 1
    	
 
    	
Information as to Layoff
    
	
Schedule 2
    	
 
    	
Equity Actions for Matthew P. Flynn
    
	
 
    	
 
    	
 
    
	
Attachment   A
    	
 
    	
Benefits   after Termination Date
    
	
Attachment   B
    	
 
    	
Form of   Employee Invention Assignment and Confidentiality Agreement
    
	
 
    	
 
    	
 
    
	
Attachment   C
    	
 
    	
Resignation   from Office
    
	
Attachment   D
    	
 
    	
Form of   Indemnification Agreement
    

 

 

Schedule 2

 

Equity Actions for Matthew P. Flynn

 

	
Grant Date
    	
 
    	
Exercise
   Price
    	
 
    	
Vested
   Shares as
   of
   February
   10, 2012
    	
 
    	
Unvested
   Shares as of
   February
   10, 2012
    	
 
    	
Effect of Separation Package
    	
 
    
	
Options 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
11/17/2008
    	
 
    	
$
    	
0.70
    	
 
    	
—
    	
 
    	
150,000
    	
 
    	
Accelerate   so fully vested; exercisable until 2/24/2013
    	
 
    
	
11/16/2009
    	
 
    	
$
    	
1.16
    	
 
    	
37,500
    	
 
    	
75,000
    	
 
    	
Accelerate   so fully vested; exercisable until 2/24/2013
    	
 
    
	
7/15/2010
    	
 
    	
$
    	
1.60
    	
 
    	
37,500
    	
 
    	
112,500
    	
 
    	
Accelerate   so fully vested; exercisable until 2/24/2013
    	
 
    
	
7/15/2011
    	
 
    	
$
    	
1.60
    	
 
    	
—
    	
 
    	
150,000
    	
 
    	
Forfeit
    	
 
    

 

 

List of Attachments Omitted from the Executive Separation Agreement by and between
 Axcelis Technologies, Inc. (“Axcelis”) and Matthew P. Flynn dated as of February 10, 2012
 as filed with the Securities Exchange Commission (the “Commission”) on Form 8-K

 

	
Schedule 1
    	
 
    	
Information as to Layoff, providing information   required by the Older Workers Benefit Protection Act in connection with a   group layoff.
    
	
 
    	
 
    	
 
    
	
Attachment   A
    	
 
    	
A   document providing detail on the status of Mr. Flynn’s employee benefits   following his termination of employment.
    
	
Attachment   B
    	
 
    	
A   copy of the form of Employee Invention Assignment and Confidentiality   Agreement used by the Company.
    
	
Attachment   C
    	
 
    	
The   form of resignation from office to be signed by Mr. Flynn.
    
	
Attachment   D
    	
 
    	
A   copy of the form of Indemnification Agreement between the Company and   Mr. Flynn.
    

 

Axcelis will furnish supplementally a copy of any omitted attachment to the Commission upon request.Exhibit 10.6

 

EXECUTION VERSION

 

AMENDMENT AGREEMENT

 

Dated as of January 19, 2012

 

by and among

 

AMPHENOL FUNDING CORP.,
 as Seller,

 

AMPHENOL CORPORATION,
 as Servicer,

 

ATLANTIC ASSET SECURITIZATION LLC,
 as Conduit Purchaser,

 

and

 

CRÉDIT AGRICOLE CORPORATE
 AND INVESTMENT BANK
 as Administrative Agent for the Purchasers
 and Related Committed Purchaser

 

 

This AMENDMENT AGREEMENT (this “Agreement”), dated as of January 19, 2012 (the “Amendment Effective Date”), is by and among Amphenol Funding Corp., a Delaware corporation, as Seller (“AFC”), Amphenol Corporation, a Delaware corporation, as Servicer (“Amphenol”), Atlantic Asset Securitization LLC, a Delaware limited liability company, as Conduit Purchaser (“Atlantic”), and Crédit Agricole Corporate and Investment Bank, f/k/a Calyon New York Branch, a French banking corporation, duly licensed under the laws of the State of New York, as Administrative Agent for the Purchasers and as the sole Related Committed Purchaser as of the date hereof (“Crédit Agricole”).

 

Reference is hereby made to (i) that certain Receivables Purchase Agreement, dated as of July 31, 2006, as amended on May 26, 2009, May 25, 2010, February 1, 2011 and September 9, 2011 (as amended or otherwise modified, the “Receivables Purchase Agreement”), among AFC, Amphenol, Atlantic and Crédit Agricole; and (ii) that certain Amended and Restated Fee Letter, dated as of May 25, 2010 (as amended or otherwise modified, the “Fee Letter”).

 

RECITALS

 

WHEREAS, the parties hereto wish to amend the Receivables Purchase Agreement, as herein set forth;

 

WHEREAS, AFC desires that Crédit Agricole extend its Commitment in its capacity as a Related Committed Purchaser under the Receivables Purchase Agreement, and Crédit Agricole is willing to extend such Commitment;

 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

ARTICLE I
 DEFINED TERMS

 

SECTION 1.1  Capitalized terms used herein and not otherwise defined shall have the meaning set forth in the Receivables Purchase Agreement.

 

ARTICLE II
 AMENDMENTS TO THE AFFECTED DOCUMENTS

 

SECTION 2.1  Amendments to Receivables Purchase Agreement.

 

(a)                                 The definition of Commitment Expiry Date in Exhibit I to the Receivables Purchase Agreement is hereby amended in its entirety as follows:

 

“Commitment Expiry Date” means for any Related Committed Purchaser, January 17, 2013, as such date may be extended from time to time in the sole discretion of such Related Committed Purchaser pursuant to Section 1.12 of the Receivables Purchase Agreement.

 

(b)                                 The definition of Scheduled Commitment Expiry Date in Exhibit I to the Receivables Purchase Agreement is herby amended in its entirety as follows:

 

 

“Scheduled Commitment Expiry Date” means January 17, 2013.

 

(c)                                  The definition of Scheduled Facility Termination Date in Exhibit I to the Receivables Purchase Agreement is hereby amended in its entirety as follows:

 

“Scheduled Facility Termination Date” means January 17, 2013.

 

SECTION 2.2  Amendments to Fee Letter

 

(a)                                 Concurrently with the execution of this Agreement, the parties hereto are entering into an amendment and restatement of the Fee Letter (the “Amended Fee Letter”), to be dated as of the date hereof and containing certain modifications to the terms thereof, and the parties hereto agree that the definition of “Fee Letter” in Section 1.7 of the Receivable Purchase Agreement shall be deemed to refer to the Amended Fee Letter from and after its execution and delivery.

 

ARTICLE III
 CONDITIONS TO EFFECTIVENESS

 

SECTION 3.1  Amendment Effective Date.  This Agreement and the provisions contained herein shall become effective as of the date hereof, provided that Crédit Agricole shall have, in form and substance satisfactory to it, received an original counterpart (or counterparts) of this Agreement executed by each of the parties hereto.

 

ARTICLE IV
 NOTICE, CONFIRMATION, ACKNOWLEDGEMENT,
 RELEASE AND REPRESENTATIONS AND WARRANTIES

 

SECTION 4.1  Notice.  Each party hereto hereby acknowledges timely notice of the execution of this Agreement and of the transactions and amendments contemplated hereby.  Each party hereto hereby waives any notice requirement contained in the Transaction Documents with respect to the execution of this Agreement.

 

SECTION 4.2  Confirmation of the Subject Documents.  The parties hereto each hereby acknowledge and agree that, except as herein expressly amended, the Receivables Purchase Agreement and each other Transaction Document are each ratified and confirmed in all respects and shall remain in full force and effect in accordance with their respective terms.

 

SECTION 4.3  Representations and Warranties.  By its signature hereto, each party hereto hereby represents and warrants that, before and after giving effect to this Agreement, as follows:

 

(a)                Its representations and warranties set forth in the Transaction Documents (as amended hereby) are true and correct as if made on the date hereof, except to the extent they expressly relate to an earlier date, and except for matters that have been disclosed to Crédit Agricole in writing; and

 

2

 

(b)                No Termination Event (as defined in the Receivables Purchase Agreement) has occurred and is continuing.

 

ARTICLE V
 MISCELLANEOUS

 

SECTION 5.1  GOVERNING LAW.  THIS AGREEMENT SHALL BE DEEMED TO BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK).

 

SECTION 5.2  Execution in Counterparts.  This Agreement may be executed in any number of counterparts, each of which, when so executed, shall be deemed to be an original, and all of which, when taken together, shall constitute one and the same agreement.

 

SECTION 5.3  WAIVER OF JURY TRIAL.  EACH OF THE PARTIES HERETO WAIVES THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT BY ANY OF THE PARTIES AGAINST ANY OTHER PARTY OR PARTIES, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS OR OTHERWISE.  EACH OF THE PARTIES HERETO AGREES THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING THE FOREGOING, EACH OF THE PARTIES HERETO FURTHER AGREES THAT ITS RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION AS TO ANY ACTION, COUNTERCLAIM OR OTHER PROCEEDING THAT SEEKS, IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF THIS AGREEMENT OR ANY PROVISION HEREOF. THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT.

 

SECTION 5.4  Entire Agreement.  This Agreement, the Receivables Purchase Agreement, as amended by this Agreement, and the other Transaction Documents, as amended by this Agreement, embody the entire agreement and understanding of the parties hereto and supersede any and all prior agreements, arrangements and understandings relating to the matters provided for herein.

 

SECTION 5.5  Headings.  The captions and headings of this Agreement are for convenience of reference only and shall not affect the interpretation hereof or thereof.

 

SECTION 5.6  Severability.  If any provision of this Agreement, or the application thereof to any party or any circumstance, is held to be unenforceable, invalid or illegal (in whole or in part) for any reason (in any jurisdiction), the remaining terms of this Agreement, modified by the deletion of the unenforceable, invalid or illegal portion (in any relevant jurisdiction), will continue in full force and effect, and such unenforceability, invalidity or illegality will not otherwise affect the enforceability, validity or legality of the remaining terms of this Agreement 

 

3

 

so long as this Agreement, as so modified, continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the deletion of such portion of this Agreement will not substantially impair the respective expectations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.

 

SECTION 5.7  SUBMISSION TO JURISDICTION.  ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK OR OF THE UNITED STATES FOR THE SOUTHERN DISTRICT OF NEW YORK; AND, BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH OF THE PARTIES HERETO CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE NON-EXCLUSIVE JURISDICTION OF THOSE COURTS.  EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES, TO THE MAXIMUM EXTENT PERMITTED BY LAW, ANY OBJECTION, INCLUDING ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, THAT IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THIS AGREEMENT OR ANY DOCUMENT RELATED HERETO. EACH OF THE PARTIES HERETO WAIVES PERSONAL SERVICE OF ANY SUMMONS, COMPLAINT OR OTHER PROCESS, WHICH SERVICE MAY BE MADE BY ANY OTHER MEANS PERMITTED BY NEW YORK LAW.

 

4

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first above written.

 

	
 
    	
AMPHENOL   FUNDING CORP.,
    
	
 
    	
as   Seller
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    	
 
    
	
 
    	
Address:
    
	
 
    	
 
    	
358   Hall Avenue
    
	
 
    	
 
    	
Wallingford,   Connecticut  06492
    
	
 
    	
 
    	
Attention:
    	
Treasurer
    
	
 
    	
 
    	
Facsimile:   
    	
(203)   265-8623
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
AMPHENOL   CORPORATION,
    
	
 
    	
individually   and as Servicer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    	
 
    
	
 
    	
Address:
    
	
 
    	
 
    	
358   Hall Avenue
    
	
 
    	
 
    	
Wallingford,   Connecticut  06492
    
	
 
    	
 
    	
Attention:
    	
Treasurer
    
	
 
    	
 
    	
Facsimile:   
    	
(203)   265-8623
    
	
 
    	
 
    	
 
    
						

 

S-1

 

	
 
    	
ATLANTIC   ASSET SECURITIZATION LLC,
    
	
 
    	
as   Conduit Purchaser
    
	
 
    	
 
    
	
 
    	
By:
    	
CRÉDIT   AGRICOLE CORPORATE AND
    
	
 
    	
 
    	
INVESTMENT   BANK,
    
	
 
    	
 
    	
as   Attorney-in-fact
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
Address:
    
	
 
    	
 
    	
Deric   Bradford
    
	
 
    	
 
    	
c/o   Crédit Agricole Corporate and
    
	
 
    	
 
    	
Investment   Bank
    
	
 
    	
 
    	
1301   Avenue of the Americas, 17th Floor
    
	
 
    	
 
    	
New   York, NY 10019
    
	
 
    	
 
    	
Phone:   212-261-3470
    
	
 
    	
 
    	
Facsimile:   917-849-5584
    
					

 

S-2

 

	
 
    	
CRÉDIT   AGRICOLE CORPORATE AND
    
	
 
    	
INVESTMENT   BANK,
    
	
 
    	
as   Administrative Agent
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
Address:
    
	
 
    	
 
    	
Deric   Bradford
    
	
 
    	
 
    	
c/o   Crédit Agricole Corporate and
    
	
 
    	
 
    	
Investment   Bank
    
	
 
    	
 
    	
1301   Avenue of the Americas, 17th Floor
    
	
 
    	
 
    	
New   York, NY 10019
    
	
 
    	
 
    	
Phone:   212-261-3470
    
	
 
    	
 
    	
Facsimile:   917-849-5584
    
					

 

S-3

 

	
 
    	
CRÉDIT   AGRICOLE CORPORATE AND
    
	
 
    	
INVESTMENT   BANK,
    
	
 
    	
as   a Related Committed Purchaser for Atlantic Asset Securitization LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
Name:   
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
Address:
    
	
 
    	
 
    	
Deric   Bradford
    
	
 
    	
 
    	
c/o   Crédit Agricole Corporate and
    
	
 
    	
 
    	
Investment   Bank
    
	
 
    	
 
    	
1301   Avenue of the Americas, 17th Floor
    
	
 
    	
 
    	
New   York, NY 10019
    
	
 
    	
 
    	
Phone:   212-261-3470
    
	
 
    	
 
    	
Facsimile:   917-849-5584
    
					

 

S-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]